Cargando…

Current Antiviral Therapy for Chronic Hepatitis B

During the past decade, major breakthroughs have been achieved in treatment of chronic hepatitis B. Currently, three therapeutic agents are approved for chronic hepatitis B: interferon-alpha, lamivudine and adefovir dipivoxil. In patients with HBeAg-positive chronic hepatitis B, all of these drugs a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Young-Suk, Suh, Dong Jin
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2004
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816878/ https://www.ncbi.nlm.nih.gov/pubmed/15308835 http://dx.doi.org/10.3346/jkms.2004.19.4.489

Ejemplares similares

Management of Antiviral Resistance in Chronic Hepatitis B
por: Lim, Young-Suk
Publicado: (2017)

Current Trend in Antiviral Therapy for Chronic Hepatitis B
por: Chien, Rong-Nan, et al.
Publicado: (2022)

Antiviral therapy for chronic hepatitis B in China
por: Zheng, Xin, et al.
Publicado: (2014)

Current Antiviral Therapy of Chronic Hepatitis B: Efficacy and Safety
por: Lam, Yuk-Fai, et al.
Publicado: (2011)

Adverse effects of oral antiviral therapy in chronic hepatitis B
por: Kayaaslan, Bircan, et al.
Publicado: (2017)

Antiviral efficacies of currently available rescue therapies for multidrug-resistant chronic hepatitis B
por: Park, Mi Sung, et al.
Publicado: (2013)

Advances in new antivirals for chronic hepatitis B
por: Tang, Yanhua, et al.
Publicado: (2022)

Discontinuation of antiviral therapy in chronic hepatitis B patients
por: Medas, Renato, et al.
Publicado: (2021)

Current therapy for chronic hepatitis C: The role of direct-acting antivirals
por: Li, Guangdi, et al.
Publicado: (2017)

The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
por: Varbobitis, Ioannis, et al.
Publicado: (2016)

Antiviral Therapy in Chronic Hepatitis B With Mild Acute Exacerbation
por: Lin, Su, et al.
Publicado: (2017)

Benefits and Risks of Antiviral Treatment during Pregnancy in Patients with Chronic Hepatitis B
por: Lee, Yoon Seok, et al.
Publicado: (2021)

Current Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B
por: Kim, Soon Sun, et al.
Publicado: (2011)

Combination Therapy for Chronic Hepatitis B: Current Updates and Perspectives
por: Su, Tung-Hung, et al.
Publicado: (2017)

Current Therapy of Chronic Viral Hepatitis B, C and D
por: Schlaak, Jörg F.
Publicado: (2023)

Recent Advances in Antiviral Therapy for Chronic Hepatitis C
por: Tamori, Akihiro, et al.
Publicado: (2016)

Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections(†)
por: De Clercq, Erik, et al.
Publicado: (2010)

The treatment of chronic hepatitis B: Focus on adefovir-like antivirals
por: Tillmann, Hans Ludger
Publicado: (2008)

Novel Antivirals in Clinical Development for Chronic Hepatitis B Infection
por: Mak, Lung-Yi, et al.
Publicado: (2021)

Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy
por: Chang, Jin Won, et al.
Publicado: (2021)

Primary Hepatic Small-Cell Carcinoma Developed during Antiviral Treatment for Chronic Hepatitis B
por: Kim, Suk Bae
Publicado: (2015)

Time for an active antiviral therapy for hepatitis B: An update on the management of hepatitis B virus infection
por: Chae, Hee Bok, et al.
Publicado: (2007)

Current Treatment of Acute and Chronic Hepatitis E Virus Infection: Role of Antivirals
por: Shrestha, Ananta, et al.
Publicado: (2017)

Adherence and perceived barriers to oral antiviral therapy for chronic hepatitis B
por: Xu, Kerui, et al.
Publicado: (2018)

Access to antiviral therapy for chronic hepatitis B during COVID-19
por: Bertolli¹, Marilia Rocha, et al.
Publicado: (2022)

Predictive validation of qualitative fibrosis staging in patients with chronic hepatitis B on antiviral therapy
por: Lee, Hye Won, et al.
Publicado: (2019)

An Updated View on the Antiviral Therapy of Hepatitis C in Chronic Kidney Disease
por: Fabrizi, Fabrizio, et al.
Publicado: (2021)

Metabolic syndrome in chronic hepatitis C infection: does it still matter in the era of directly acting antiviral therapy?
por: Lim, TR
Publicado: (2014)

Disease Progression in Chronic Hepatitis B Patients under Long-Term Antiviral Therapy
por: Moon, Jin Chang, et al.
Publicado: (2015)

Occult Hepatitis B Virus Infection in Patients With Chronic Hepatitis C Treated With Antiviral Therapy
por: Caviglia, Gian Paolo, et al.
Publicado: (2012)

Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections
por: Rehermann, Barbara, et al.
Publicado: (2015)

How Durable Is Functional Cure (Hepatitis B Surface Antigen Loss) in Patients With Chronic Hepatitis B Treated With Current Antivirals?
por: Loglio, Alessandro, et al.
Publicado: (2020)

Long-Term Effects of Antiviral Therapy in Patients with Chronic Hepatitis C
por: Kagawa, Tatehiro, et al.
Publicado: (2010)

Hydroxyurea: A useful adjunct to the standard antiviral therapy in chronic hepatitis B
por: Alavi-Moghaddam, Mostafa
Publicado: (2011)

Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy
por: Huang, Chung-Feng, et al.
Publicado: (2020)

Antiviral Therapy of Liver Cirrhosis Related to Hepatitis B Virus Infection
por: Lu, Lun-Gen
Publicado: (2014)

Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma
por: Merli, Michele, et al.
Publicado: (2016)

Antiviral Therapy in Lamivudine-Resistant Chronic Hepatitis B Patients: A Systematic Review and Network Meta-Analysis
por: Wang, Hui-Lian, et al.
Publicado: (2016)

Combination Therapy for Chronic Hepatitis B: Current Indications
por: Paul, Navin, et al.
Publicado: (2011)

Review article: switching patients with chronic hepatitis B to tenofovir alafenamide—a review of current data
por: Lim, Young‐Suk, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jlj4e5di58ibinodl6hojkafpj